サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1657980

体外受精サービス市場の評価：手順タイプ別、サービスプロバイダー別、エンドユーザー別、地域別、機会および予測、2018～2032年

In-Vitro Fertilization Services Market Assessment, By Procedure Type, By Service Provider, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 247 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
体外受精サービス市場の評価：手順タイプ別、サービスプロバイダー別、エンドユーザー別、地域別、機会および予測、2018～2032年
出版日: 2025年02月19日
発行: Market Xcel - Markets and Data
ページ情報: 英文 247 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外受精サービスの世界市場は、予測期間2025-2032年にCAGR 10.30％を記録し、2024年の236億7,000万米ドルから2032年には518億6,000万米ドルに成長すると予測されています。最近の体外受精（IVF）法の開発と効果的なソリューションに対するニーズの高まりにより、体外受精サービスの世界市場は大きく拡大しています。環境要因の変化や座りがちなライフスタイルのために、人口の大半で生殖機能が低下していることが、市場拡大を促す主な要因の1つです。国民の多くは可処分所得があるため、健康に気を配り、特にこのような人生を左右するような重要な手術に関しては、自分の幸福のために費やすことができます。さらに、ヘルスケア・インフラへの政府投資、技術改善、最先端技術へのニーズの高まりが、市場の成長軌道を強化しています。新興地域、特にアジア太平洋地域におけるヘルスケアの急速な改善は、収益機会を提供しています。例えば、Conceptions Reproductive Associates of Colorado（Conceptions）は2023年8月にReproductive Medicine Associates（RMA）に買収されました。コロラド州にあるコンセプションズの4つの不妊治療クリニックは、この買収の一環としてRMAに加わる。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 体外受精サービスの世界市場の展望、2018年～2032年

  • 市場規模の分析と予測
    • 金額別
  • 市場シェア分析と予測
    • 手順タイプ別
      • 新鮮ドナーによる体外受精
      • 新鮮な非ドナー体外受精
      • 凍結ドナー体外受精
      • 凍結非ドナー体外受精
      • 自然周期体外受精
      • 胚バンキング（凍結保存）
    • サービスプロバイダー別
      • 不妊治療クリニック
      • 病院
      • 外科センター
      • クライオバンク
    • エンドユーザー別
      • カップル（男性と女性の不妊症）
      • 独身女性
      • LGBTQ+コミュニティ
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東およびアフリカ
    • 市場シェア分析（上位5社およびその他- 金額別、2024年）、企業別
  • 市場マップ分析、2024年
    • 手順タイプ別
    • サービスプロバイダー別
    • エンドユーザー別
    • 地域別

第5章 北米の体外受精サービス市場の展望、2018年～2032年

  • 市場規模の分析と予測
    • 金額別
  • 市場シェア分析と予測
    • 手順タイプ別
      • 新鮮ドナーによる体外受精
      • 新鮮な非ドナー体外受精
      • 凍結ドナー体外受精
      • 凍結非ドナー体外受精
      • 自然周期体外受精
      • 胚バンキング（凍結保存）
    • サービスプロバイダー別
      • 不妊治療クリニック
      • 病院
      • 外科センター
      • クライオバンク
    • エンドユーザー別
      • カップル（男性と女性の不妊症）
      • 独身女性
      • LGBTQ+コミュニティ
    • 国別シェア
      • 米国
      • カナダ
      • メキシコ
  • 国別市場評価
    • 米国の体外受精サービス市場の見通し、2018年～2032年
      • 市場規模の分析と予測
      • 市場シェア分析と予測

すべてのセグメントは、対象となるすべての地域と国で提供されます。

第6章 欧州の体外受精サービス市場の展望、2018年～2032年

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第7章 アジア太平洋の体外受精サービス市場の展望、2018年～2032年

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第8章 南米の体外受精サービス市場の見通し、2018年～2032年

  • ブラジル
  • アルゼンチン

第9章 中東およびアフリカの体外受精サービス市場の見通し、2018年～2032年

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第10章 需要供給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

  • 市場促進要因
  • 市場の課題

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

第18章 ケーススタディ

第19章 競合情勢

  • 市場リーダー上位5社の競合マトリックス
  • 上位5社のSWOT分析
  • 市場上位10社の主要企業の情勢
    • Weill Cornell Medicine
      • 会社概要
      • 主要経営陣
      • 製品とサービス
      • 財務状況（報告通り）
      • 主な市場フォーカスと地理的プレゼンス
      • 最近の動向/コラボレーション/ パートナーシップ/合併と買収
    • IVI-RMA Global（Spain）
    • Dunya IVF Clinic（North Cyprus）
    • Kyrenia IVF Center（North Cyprus）
    • Memorial Sisli Hospital IVF Center（Turkey）
    • Gennet City Fertility（United Kingdom）
    • Dr. Ricardo Garcia Clinic（Mexico）
    • Takara IVF Bangkok（Thailand）
    • Azul Fertility Experts（Spain）
    • Beta Plus Fertility Clinic（Greece）

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第20章 戦略的提言

第21章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 3. Global In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 4. Global In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global In-Vitro Fertilization Services Market Share (%), By Region, 2018-2032F
  • Figure 6. North America In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 8. North America In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 9. North America In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 11. United States In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 13. United States In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 14. United States In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 17. Canada In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 18. Canada In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 21. Mexico In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 22. Mexico In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 25. Europe In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 26. Europe In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 30. Germany In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 31. Germany In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 32. France In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 34. France In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 35. France In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 38. Italy In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 39. Italy In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 42. United Kingdom In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 43. United Kingdom In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 46. Russia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 47. Russia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 50. Netherlands In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 51. Netherlands In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 54. Spain In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 55. Spain In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 58. Turkey In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 59. Turkey In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 62. Poland In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 63. Poland In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 66. South America In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 67. South America In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 71. Brazil In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 72. Brazil In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 75. Argentina In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 76. Argentina In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 79. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 80. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 82. India In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 84. India In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 85. India In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 86. China In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 88. China In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 89. China In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 92. Japan In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 93. Japan In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 96. Australia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 97. Australia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 100. Vietnam In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 101. Vietnam In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 104. South Korea In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 105. South Korea In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 108. Indonesia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 109. Indonesia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 112. Philippines In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 113. Philippines In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 116. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 117. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa In-Vitro Fertilization Services Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 121. Saudi Arabia In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 122. Saudi Arabia In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 125. UAE In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 126. UAE In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa In-Vitro Fertilization Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa In-Vitro Fertilization Services Market Share (%), By Procedure Type, 2018-2032F
  • Figure 129. South Africa In-Vitro Fertilization Services Market Share (%), By Service Provider, 2018-2032F
  • Figure 130. South Africa In-Vitro Fertilization Services Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Procedure Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Service Provider Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX12762

Global in-vitro fertilization services market is projected to witness a CAGR of 10.30% during the forecast period 2025-2032, growing from USD 23.67 billion in 2024 to USD 51.86 billion in 2032. Recent developments in in-vitro fertilization (IVF) methods and the rising need for effective solutions have seen a huge expansion in the global market for in-vitro fertilization services. Declining reproductive health in most of the population due to changing environmental factors and sedentary lifestyles is one of the main reasons driving market expansion. Most of the population has a disposable income to take care of their health and spend on their well-being especially when it comes to such critical and life-altering operations. In addition, government investments in healthcare infrastructure, technological improvements, and the increasing need for state-of-the-art technologies are reinforcing the market's growth trajectory. Fast improvements in healthcare in emerging regions, especially in Asia-Pacific, offer profitable opportunities. For example, Conceptions Reproductive Associates of Colorado (Conceptions) was acquired by Reproductive Medicine Associates (RMA) in August 2023. Four of Conceptions' fertility clinics in Colorado will join RMA as part of the transaction.

Changing Lifestyles Among People Boost Market Growth

Lifestyle changes have greatly contributed to the increased demand for in vitro fertilization (IVF) services globally. The growing tendency of postponed motherhood, fueled by late marriages, financial preparation, and career goals, is one of the main causes. Fertility decreases with maternal age, which is why many couples turn to assisted reproductive technologies (ART) such as IVF. Furthermore, hormonal imbalances and issues related to the reproductive system in both men and women have been connected to contemporary lives marked by high levels of stress, erratic sleep patterns, and unhealthy eating habits. Fertility treatments are required because of disorders including polycystic ovarian syndrome (PCOS) and decreased sperm quality, which are further aggravated by sedentary behavior and rising obesity rates. Furthermore, environmental risks that have been linked to decreased reproductive health include exposure to radiation, pollution, and endocrine-disrupting chemicals (EDCs). Substance abuse, such as excessive drinking, smoking, and drug use, also impairs fertility, leading some people to turn to IVF as a remedy. The IVF market is also growing because of changing social conventions, such as the growing acceptance of single parents and same-sex couples choosing assisted reproduction.

The need for IVF services is anticipated to increase as these lifestyle factors continue to affect conception rates, propelling improvements in reproductive medicine and increasing access to fertility care globally. For instance, as of 2023, approximately 12 million children have been born through assisted reproductive technologies (ART), with over 500,000 IVF deliveries occurring annually.

Technological Development and Integration of AI Fuel Market Growth

Due to technological improvements that have improved treatment efficiency and success rates, the global market is expanding significantly. IVF has become a more dependable choice for infertile couples over the past years because of advancements such as time-lapse imaging, preimplantation genetic testing (PGT), and embryo vitrification, which have increased implantation rates and decreased miscarriage risks. In addition to boosting patient confidence, these technical advancements have broadened the pool of eligible patients to include people with age-related infertility or genetic problems.

IVF is further revolutionized by automation and artificial intelligence (AI), which minimize human error and optimize embryo selection. Due to AI-driven models' capacity to precisely assess embryo viability, pregnancy success rates are surging. Furthermore, patients can maintain their fertility for later use by using cryopreservation techniques, such as storing oocytes and embryos, which raises the need for IVF services. IVF treatments are now more widely available and reasonably priced because of these developments, growing awareness, and increased investments in fertility clinics. Therefore, technological advancements in IVF remain a major driver of the market's steady expansion. For instance, a company based in the field of AI-based solutions for IVF clinics, called AIVF Ltd., joined forces with Genea Biomedx Pty Ltd, a medical device provider for IVF laboratories, in May 2023, to create a comprehensive and cost-effective integrated systems solution for personalized IVF. The collaboration brought together Genea Biomedx's Geri time-lapse incubator and AIVF Ltd.'s EMA AI platform, creating a powerful suite that offers widespread access to personalized and optimized IVF treatments.

Frozen Non-Donor IVF Segment Spearheads the Market Growth

Considering the market size and popularity, frozen non-donor IVF dominates the other IVF procedures because of its higher success rates, cost-effectiveness, and flexibility compared to fresh cycles. In this process, a woman's embryos from a prior cycle are frozen and used for implantation later. Due to improvements in cryopreservation methods, especially vitrification, frozen embryo transfers now have success rates that are on par with or even greater than those of fresh embryo transfers. One of the main benefits of frozen non-donor IVF is that it lessens the financial and physical burden on patients. Frozen cycles do not require recurrent ovarian stimulation and egg retrieval, which makes the procedure less invasive and less expensive than fresh IVF cycles.

Furthermore, frozen embryos are frequently subjected to preimplantation genetic testing (PGT), which guarantees the selection of genetically sound embryos and raises the likelihood of a successful pregnancy while lowering the risk of miscarriage. The demand for this operation has been greatly increased by the growing trend of fertility preservation, in which women preserve their embryos for later use. Furthermore, frozen non-donor IVF is a key driver of development in the global IVF market owing to the growing awareness, accessibility, and success of frozen cycles, further expanding its usage globally. Ovation Fertility and US Fertility merged in May 2023 to build a fertility platform that provides IVF and advanced fertility care, such as Frozen Non-Donor IVF, in the United States.

North America Dominates In-Vitro Fertilization Services Market Share

Due to strong regulatory support, high infertility rates, and advanced healthcare infrastructure, North America leads the global in-vitro fertilization (IVF) market. Due to delayed parenthood, changing lifestyle patterns, and greater awareness of fertility treatments, the region, especially the United States and Canada, has seen an increase in demand for assisted reproductive technologies (ART).

Furthermore, infertility issues affect a sizable section of the population, with variables such as stress, obesity, and environmental contaminants contributing to dwindling fertility rates. Technological developments further improve IVF success rates in North America in Preimplantation Genetic Testing (PGT), embryo cryopreservation, and artificial intelligence (AI)-based embryo selection. IVF is now more accessible to a wider audience due to the widespread availability of fertility clinics and specialist IVF centers and rising insurance coverage for infertility treatments. Furthermore, the market's reach has been broadened by the increasing acceptance of IVF among single parents and the LGBTQ+ community.

Innovative fertility solutions have been developed more quickly due to government initiatives and strong R&D funding from the corporate and governmental sectors. For instance, the U.S. FDA regulates drugs and devices used in IVF, followed by the CDC's implementation of the Fertility Clinic Success Rate and Certification Act. Moreover, semen analysis and sperm function tests are high-complexity tests regulated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) in the U.S. Strict compliance with standards and on-site inspections are essential. Significant medical tourism is also drawn to the area, especially by individuals seeking advanced care. Together, these factors position North America as the largest IVF market, with further expansion anticipated in the future.

Future Market Scenario (2025 - 2032F)

Many factors claim the growth of the in-vitro fertilization services market. Technological advancements provide faster, more accurate and promising results. Opportunity also lies in the increasing number of populations aware of such alternatives and choosing to beat the taboo associated with it. Promising government encompass providing healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone. For instance, the capabilities of FUJIFILM Irvine Scientific, Inc.'s Presagen's Life Whisperer platform were extended in June 2023 to support clinical decision-making in IVF.

Key Players Landscape and Outlook

Key service providers in the in-vitro fertilization services industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, Merck KGaA launched Fertility Counts in May 2023 to address the social, economic, and societal issues brought on by low birth rates in the Asia-Pacific area.

Furthermore, Boston IVF and Cryoport, Inc. signed a three-year supply chain solutions agreement in April 2023 to facilitate shipping reproductive materials across the United States.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Procedure Type
      • 4.2.1.1. Fresh Donor IVF
      • 4.2.1.2. Fresh Non-Donor IVF
      • 4.2.1.3. Frozen Donor IVF
      • 4.2.1.4. Frozen Non-Donor IVF
      • 4.2.1.5. Natural Cycle IVF
      • 4.2.1.6. Embryo Banking (Cryopreservation)
    • 4.2.2. By Service Provider
      • 4.2.2.1. Fertility Clinics
      • 4.2.2.2. Hospitals
      • 4.2.2.3. Surgical Centers
      • 4.2.2.4. Cryobanks
    • 4.2.3. By End-user
      • 4.2.3.1. Couples (Male & Female Infertility)
      • 4.2.3.2. Single Women
      • 4.2.3.3. LGBTQ+ Community
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Procedure Type
    • 4.3.2. By Service Provider
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America In-Vitro Fertilization Services Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Procedure Type
      • 5.2.1.1. Fresh Donor IVF
      • 5.2.1.2. Fresh Non-Donor IVF
      • 5.2.1.3. Frozen Donor IVF
      • 5.2.1.4. Frozen Non-Donor IVF
      • 5.2.1.5. Natural Cycle IVF
      • 5.2.1.6. Embryo Banking (Cryopreservation)
    • 5.2.2. By Service Provider
      • 5.2.2.1. Fertility Clinics
      • 5.2.2.2. Hospitals
      • 5.2.2.3. Surgical Centers
      • 5.2.2.4. Cryobanks
    • 5.2.3. By End-user
      • 5.2.3.1. Couples (Male & Female Infertility)
      • 5.2.3.2. Single Women
      • 5.2.3.3. LGBTQ+ Community
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States In-Vitro Fertilization Services Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Procedure Type
          • 5.3.1.2.1.1. Fresh Donor IVF
          • 5.3.1.2.1.2. Fresh Non-Donor IVF
          • 5.3.1.2.1.3. Frozen Donor IVF
          • 5.3.1.2.1.4. Frozen Non-Donor IVF
          • 5.3.1.2.1.5. Natural Cycle IVF
          • 5.3.1.2.1.6. Embryo Banking (Cryopreservation)
        • 5.3.1.2.2. By Service Provider
          • 5.3.1.2.2.1. Fertility Clinics
          • 5.3.1.2.2.2. Hospitals
          • 5.3.1.2.2.3. Surgical Centers
          • 5.3.1.2.2.4. Cryobanks
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Couples (Male & Female Infertility)
          • 5.3.1.2.3.2. Single Women
          • 5.3.1.2.3.3. LGBTQ+ Community

All segments will be provided for all regions and countries covered

6. Europe In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Turkey
  • 6.9. Poland

7. Asia-Pacific In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa In-Vitro Fertilization Services Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

18. Case Studies

19. Competitive Landscape

  • 19.1. Competition Matrix of Top 5 Market Leaders
  • 19.2. SWOT Analysis for Top 5 Players
  • 19.3. Key Players Landscape for Top 10 Market Players
    • 19.3.1. Weill Cornell Medicine
      • 19.3.1.1. Company Details
      • 19.3.1.2. Key Management Personnel
      • 19.3.1.3. Products and Services
      • 19.3.1.4. Financials (As Reported)
      • 19.3.1.5. Key Market Focus and Geographical Presence
      • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 19.3.2. IVI-RMA Global (Spain)
    • 19.3.3. Dunya IVF Clinic (North Cyprus)
    • 19.3.4. Kyrenia IVF Center (North Cyprus)
    • 19.3.5. Memorial Sisli Hospital IVF Center (Turkey)
    • 19.3.6. Gennet City Fertility (United Kingdom)
    • 19.3.7. Dr. Ricardo Garcia Clinic (Mexico)
    • 19.3.8. Takara IVF Bangkok (Thailand)
    • 19.3.9. Azul Fertility Experts (Spain)
    • 19.3.10. Beta Plus Fertility Clinic (Greece)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer